CIK 0001390478
- Non-accelerated filer
- Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-200-5278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- S-1/A Offering Registration Statement
- S-1 Offering Registration Statement
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- S-1 Offering Registration Statement
Page 10 of 10 · 198 filings